Early-Stage Lung Cancer: Screening and Management

ISBN-13: 9789811356568 / Angielski / Miękka / 2019 / 423 str.

Xiangpeng Zheng; Ming Li; Guozhen Zhang

Recenzje

"The audience is practicing physicians who are involved in the diagnosis and treatment of patients with early-stage lung cancers. This may include pulmonologists with lung cancer as their area of interest/expertise, as well as radiologists and pathologists. The book is quite comprehensive in its discussion and meets the needs of its intended audience. ... I highly recommend it." (Santosh Dhungana, Doody's Book Reviews, April, 2018)

Spis treści

The pathological advances of early lung adenocarcinoma.- Advancement in Cross-sectional Anatomy of the Lung.- Low-dose CT Screening of Lung Cancer.- The Advances of PET/CT clinical application in micronodular lung cancer.- Angiogenesis-dependent tumor progression.- Pure Ground-glass Nodules.- Part-solid Ground-glass Nodules.- Solid Pulmonary Nodules.- CT-based Categorization of Small Pulmonary Adenocarcinoma and Differential Diagnosis.- Multiple Primary Lung Cancer.- Management Strategies of Micronodular Lung Cancer: Surgical Perspectives.- Management Strategies of Early-stageLung Cancer: Stereotactic Ablative Radiation Therapy.- Radiofrequency ablation.- Case Discussion.

O autorze

Editor Xiangpeng Zheng is an associate professor and director at the department of radiation oncology, Fudan University Huadong Hospital, Shanghai, China.

Blurb

This book discusses major issues and advances in the diagnosis and treatment of incidentally detected early-stage lung cancer (ESLC). In Part I, pathology and radiology experts comprehensively review the state-of-the-art advances in individual research fields, and offer an update on the cross-sectional anatomy of the lung and post-processing techniques for CT imaging. Part II focuses on the imaging features, differential diagnosis and radiologic-pathologic correlations of ESLCs in the categories pGGN, mGGN and solid nodules in compliance with the Guidelines on Lung Cancer Screening from the National Comprehensive Cancer Network (NCCN). Part III briefly introduces therapeutic management strategies for ESLCs, including surgical and non-surgical approaches, for instance stereotactic ablative radiation therapy (SABR) and radiofrequency ablation (RFA). Lastly, the authors have meticulously prepared 50 clinical cases of pathologically proven benign and malignant pulmonary nodules with in-depth discussion and experts’ comments to further readers’ understanding of practical imaging and management strategies of ESLCs.